Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin B12 vs B3 in pediatric traumatic brain injury
NCT05958277Phase 3Completed
- Sponsor
- KRL Hospital
- Start
- Jun 2021
- Primary completion
- Jan 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of vitamin b12, cannabidiol in traumatic brain injury (TBI), sponsored by KRL Hospital. Started Jun 2021; status: completed.
02
Drugs
vitamin b12cannabidiol
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT05958277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05958277.